MedTrace Logo

Computed Tomography Angiography Prediction Score for Side Branch Occlusion

NCT03709836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 363

Last updated 2020-11-02

No results posted yet for this study

Summary

Lesions involving coronary bifurcations account for approximately 20% of all percutaneous coronary interventions (PCI). Revascularization within bifurcation sites remains technically challenging. While the most optimal interventional treatment strategy for bifurcation lesions is still debatable, side branch (SB) occlusion is one of the most serious procedural complications with prevalence rates over 7%.

Numerous mechanisms of the SB occlusion (e.g. plaque or carina shift, coronary artery dissection, thromboembolism, coronary artery spasm, etc) have been postulated. Regardless of the cause, loss of the SB is associated with increased risk of periprocedural mortality and myocardial infarction. Therefore, PCI involving coronary bifurcation mandates consideration of the risk of SB compromise. The CT-PRECISION (Computed Tomography angiography PREdiCtIon score for SIde branch Occlusion in coronary bifurcation interventioN) registry was designed to evaluate the application of coronary computed tomography angiography (coronary CTA) for the prediction of SB occlusion during percutaneous revascularization of bifurcation lesions. The main purpose of this single-center study is to develop a noninvasive CTA-based prediction tool to determine the procedural outcome of PCI in bifurcation lesions.

Conditions

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Adam D. Staruch, MD · Department of Interventional Cardiology, and Angiology, Institute of Cardiology, Warsaw, Poland

  • Maksymilian P. Opolski, MD, PhD · Department of Interventional Cardiology, and Angiology, Institute of Cardiology, Warsaw, Poland

  • Adam Witkowski, MD, PhD · Department of Interventional Cardiology, and Angiology, Institute of Cardiology, Warsaw, Poland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-25
Primary Completion
2018-12-01
Completion
2019-01-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03709836 on ClinicalTrials.gov